Literature DB >> 7230001

Potassium-induced release of [3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors.

D Dembiec, G Cohen.   

Abstract

Cocaine, nomifensine, mazindol, dita and desmethylimipramine markedly decreased the potassium-stimulated release of [3H]-dopamine from rat striatum, an area of brain enriched with dopamine. In contrast, only desmethylimipramine had a similar effect on the release of (3H]norepinephrine from the occipital cortex, a brain area comprised mainly of norepinephrine nerve terminals. These results were obtained under the following experimental conditions: the brain tissue was labeled with the appropriate [3H]catecholamine, incubated with a drug, rinsed twice with drug-free medium and subsequently stimulated with 20 mM potassium ions to induce release of the [3H]catecholamine. The radioactivity present in the medium before, during and after stimulation was primarily the unmetabolized [3H]catecholamine. The diminished response to potassium-stimulation in the striatum after exposure to drug was not related to the ability or potency of the drug to act as an inhibitor of neuronal uptake of catecholamines. The data indicate a relatively selective interaction of the drugs with dopamine nerve terminals rather than norepinephrine nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7230001

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.

Authors:  S Kowalik; M Levitt; A I Barkai
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.

Authors:  Sarah J Farnsworth; Trent J Volz; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-11-26       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.